PEPTRON
Peptron is a biotech company developing a wide range of peptide and small molecule based drugs to treat chronic and life-threatening disorders. Its initial focus is to provide long-term cure for neurodegenerative, cancer and endocrine related diseases. Peptron integrates the extensive experience of peptide research, drug development and expertise in drug delivery technologies for more than 15 years combined with a patients-focused approach driven by excellence.
PEPTRON
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-11-21
Address:
Yusong, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.peptron.co.kr
Total Employee:
11+
Status:
Active
Contact:
042-360-8880
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Mobile Non Scaleable Content US Privacy User Signal Mechanism PHP
Investors List
Agate Medical Investments
Agate Medical Investments investment in Venture Round - Peptron
Official Site Inspections
http://www.peptron.co.kr Semrush global rank: 6.85 M Semrush visits lastest month: 744
- Host name: 211.47.74.16
- IP address: 211.47.74.16
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Peptron"
Peptron
๊ณต๋์ฐ๊ตฌ/ํํธ๋๋ง. [email protected]. ํฉํ์ด๋ ์ฃผ๋ฌธ. [email protected]See details»
์ฑ์ฉ๊ณต๊ณ - peptron.co.kr
์ฑ์ฉ๋ถ์ผ; 2025๋ ๊ฐ ๋ถ๋ฌธ๋ณ ์ ์ /๊ฒฝ๋ ฅ์ฌ์ ์ฑ์ฉ; ๋ฌธ์์ ํ; 042-360-8891; ๋ฌธ์๋ฉ์ผ; [email protected]; ์ฑ์ฉ๊ตฌ๋ถ; ๋ฌด๊ด; ๋ชจ์ง๊ธฐ๊ฐSee details»
๋น์ - Peptron
โ 1997๋ ์ฐฝ๋ฆฝ ์ด๋ ํฉํ์ด๋ ๊ธฐ๋ฐ์ ํ์ ์ ์ธ ๊ธฐ์ ๊ฐ๋ฐ์ ๋งค์งํด ์จ ํฉํธ๋ก ์ ์ฝํจ์ง์์ฑ ์์ฝํ๊ณผ ํญ์ฒด ์์ฝํ, ํฉํ์ด๋ ์ ์ฝ๊ฐ๋ฐ์ ๊ฟ์ ์คํํด๊ฐ๊ณ ์์ต๋๋ค. ์์ผ๋ก๋ ํฉํธ๋ก ์ ์๋ฃ์ ์ง โฆSee details»
Peptron - Crunchbase Company Profile & Funding
Organization. Peptron . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Peptron is a biotech company. Yusong, Taejon-jikhalsi, South Korea; 11 โฆSee details»
Peptron, Inc. - LinkedIn
Peptron, Inc. | LinkedIn ํ๋ก์ 106๋ช | Our priority remains on the health, and well-being of patients and connecting science, technology and business together | Established in 1997, โฆSee details»
ํฉํธ๋ก - ๋๋ฌด์ํค
Oct 31, 2024 ์ด ์ ์๋ฌผ์ cc by-nc-sa 2.0 kr์ ๋ฐ๋ผ ์ด์ฉํ ์ ์์ต๋๋ค. (๋จ, ๋ผ์ด์ ์ค๊ฐ ๋ช ์๋ ์ผ๋ถ ๋ฌธ์ ๋ฐ ์ฝํ ์ ์ธ) ๊ธฐ์ฌํ์ ๋ฌธ์์ ์ ์๊ถ์ ๊ฐ ๊ธฐ์ฌ์์๊ฒ ์์ผ๋ฉฐ, ๊ฐ ๊ธฐ์ฌ์๋ ๊ธฐ์ฌํ์ โฆSee details»
Peptron Inc. Company Profile - South Korea | Financials & Key
Jul 5, 2024 Full name: Peptron Inc. Profile Updated: July 05, 2024 Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a โฆSee details»
Peptron Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Peptron Inc. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet. Peptron Inc. D&B โฆSee details»
Company Peptron, Inc. - MarketScreener.com
Business description: Peptron, Inc. Peptron Inc is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The โฆSee details»
Peptron (CEO Choi Ho-il, photo), which is developing a long-term ...
Oct 8, 2024 [email protected]. Input : 2024-10-08 17:28:05 Updated : 2024-10-08 20:39:28. ... Peptron (CEO Choi Ho-il, photo), which is developing a long-term obesity โฆSee details»
Peptron
ํฉํธ๋ก ์ ์ฑ๊ณต์ ์ธ ํฉํ์ด๋ ์์ฝํ์ ๊ด๊ฑด์ด๋ผ ํ ์ ์๋ ์ฝํจ์ง์์ฑ ์์ฝํ์ ์ค๊ณ ๋ฐ ์ ์กฐ์ ๋ํ ๋ ์์ ์ธ ๊ธฐ๋ฐ๊ธฐ์ ์ ๊ตฌ์ถํ์ฌ ์ฑ๊ณต์ ์ธ ์์ฝํ ๊ฐ๋ฐ์ ์ด์ด๋๊ฐ๊ณ ์์ต๋๋ค.See details»
Peptron
Dr. Seung-Gu Chang has joined in Peptron for 20 years and served as various senior positions across a range of research and finance. In 2006, he was appointed Chief Financial Officer of โฆSee details»
Peptron to boost long-acting drug production 10-fold with new
Aug 19, 2024 Peptron, a Korean biotech company, said last Friday that it will invest 65 billion won ($48.6 million) to build a new manufacturing plant for peptide-based long-acting โฆSee details»
ํฉํธ๋ก (A087010) | ๊ธฐ์ ๊ฐ์ | ๊ธฐ์ ์ ๋ณด | Company Guide
์๋ณธ๊ธ ๋ณ๋๋ด์ญ; ๋ณ๋์ผ ์์ฅ์ผ ์ข ๋ฅ ๋ณ๋์ฃผ์์ ๋ณ๋ํ์๋ณธ๊ธ; 2024/11/22 : 2024/12/04 : ์ ์์ฆ์(์ฃผ์ฃผ๋ฐฐ์ )(๋ณดํต) 2,640,000See details»
ๆฎ่ฐๆฅ,ไปฅ7ๆฅไธๅ9ๆถ30ๅไธบๅ,่ก็ฅจๆ่ตๆถ็็ๆๅๅ1%็่ถ ้ซๆ โฆ
3 days ago ๆฎ่ฐๆฅ,ไปฅ7ๆฅไธๅ9ๆถ30ๅไธบๅ,่ก็ฅจๆ่ตๆถ็็ๆๅๅ1%็่ถ ้ซๆๅไนฐๅ ฅไธๆ็ตๅญใPeptronใๆๅฑฑ่ฝๆบ็ญ่ก็ฅจๆๅคใ็ธๅ,ๅๆๅฎๆๅค็่ก็ฅจไพๆฌกๆฏ้ฉๅAerospace Kraftonใ โฆSee details»
ๆฎ่ฐๆฅ,่ก็ฅจๆ่ตๆถ็็ๆๅๅ1%็่ถ ้ซๆไปฅ7ๆฅไธๅ1ๆถ30ๅไธบๅ, โฆ
3 days ago ๆฎ่ฐๆฅ,่ก็ฅจๆ่ตๆถ็็ๆๅๅ1%็่ถ ้ซๆไปฅ7ๆฅไธๅ1ๆถ30ๅไธบๅ,ๅไนฐๅ ฅไธๆ็ตๅญใPeptronใHancom็ญ่ก็ฅจๆๅคใ็ธๅ,ๅๆๅฎๆๅค็่ก็ฅจไพๆฌกๆฏKrafton้ฉๅAerospaceใ โฆSee details»
์ฑ์ฉ๊ณต๊ณ - Peptron
Dec 2, 2024 ๋ชจ์ง๋ถ์ผ ์ฑ์ฉ๋ถ์ผ ์ ์๊ธฐ๊ฐ ์ง์; ๋ด๋ถํ๊ณ๊ด๋ฆฌ, ํ๊ณ์๊ฐ, ํฉํ์ด๋ํฉ์ฑ, ๋ฐ์ด์ค์ฐ๊ตฌ, ๋ถ์, ํนํ, ๋ฐ์ดํฐ์์ ์ฑ(di), ๊ณต์ ๊ฐ๋ฐ, ์์ฐ, ์ถํ๊ด๋ฆฌ, ํ์ง๊ด๋ฆฌ(๋ฏธ์๋ฌผ), โฆSee details»
Peptron
์ฑ์ฉ๊ณต๊ณ ์จ๋ผ์ธ ์ ์ฌ์ง์ ๋ก๊ทธ์ธ ํ๋ฉด์ ๋๋ค. ํฉํธ๋ก ์ฒ์ ์ง์ํ์๋ ์ ์ฌ์ง์์๊ป์๋ ๋จผ์ ๊ฐ์ธ์ ๋ณด๋ฑ๋ก ์ ํด์ฃผ์๊ธฐ ๋ฐ๋๋๋ค. ๋น๋ฐ๋ฒํธ๋ฅผ ์์ผ์ ๊ฒฝ์ฐ ๋น๋ฐ๋ฒํธ๋ณ๊ฒฝ ์ ํด๋ฆญ ํ ๋ฑ๋กํด โฆSee details»
NEWS - Peptron
์์ฑ์: ๊ด๋ฆฌ์: ์ผ์: 2024-08-16 21:14:20: ๊ธ์ ๋ชฉ [๋ณด๋์๋ฃ] ํฉํธ๋ก , ์ฝํจ์ง์์ฑ ์์ฝํ ์์ฐ 10๋ฐฐ ๋๋ฆฐ๋คโฆ์ ๊ณต์ฅ ๊ฑด๋ฆฝ์ 650์ต์ ํฌ์See details»
Parkinsonโs Disease - peptron.co.kr
Organization; Corporate Governance; ... In 2014, Peptron licensed in the exclusive right of the National Institutes of Health(NIH) patent for the use of GLP-1 agonists for the treatment of โฆSee details»